Peter Mac oncologist Dr Julia Dixon-Douglas has received an International Fellowship Grant enabling her to take a post at Europe’s leading cancer hospital and research centre.
This Breast Cancer Trials initiative supports early-career breast cancer researchers to further their research, experience and connections overseas.
Dr Dixon-Douglas has taken a post at Institut Gustave Roussy, in France, where she will continue her research into how best to use immunotherapy and other latest treatments for breast cancer.
“In the last few years it has been really exciting to see that there have been a whole range of new treatments become available for patients with breast cancer,” Dr Dixon-Douglas says.
“But we are really just at the starting line in terms of understanding which patients will benefit most from those treatments.”
Dr Dixon-Douglas’ research into biomarkers aims to provide a way to predict which treatment, or combination or sequence of treatments, should work best for each patient.
This “individualised care” aims to “achieve the best cancer outcomes for patients but will also minimise the risk of unnecessary side-effects”, she says.
Learn more about Dr Dixon-Douglas’ research in this extended podcast interview recorded by Breast Cancer Trials or watch below.